Taiwan Diabetes Registry (TDR)
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 24,000
- Locations
- 1
- Primary Endpoint
- Provide data on patient characteristics
Study Overview
Brief Summary
To Investigate the Risk Factors, Life Style and Treatments of the Microvascular Disease，Macrovascular Disease and Neuropathy in Patients With Diabetes.
Detailed Description
At the first year (2015), the patients ever enrolled into the quality control study by Taiwan Association of Diabetes Educators in 2006 and 2011 will be recruited, and their relevant clinical data will be regularly registered yearly until 2030. In addition, it is planned that type 1 diabetic patients will be enrolled, and their clinical data will be regularly recorded yearly until 2030. Also, newly diagnosed type 2 diabetic patients will be recruited, and their clinical data will be regularly entered to the diabetes web-based system yearly until 2030. We will also include pregnant patients with diabetes since 2023, and their data will be monitored and followed until 2030. Finally, we will also include pregnant patients with diabetes since 2023, and their data will be monitored and followed until 2030.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Diagnosis of diabetes mellitus
Exclusion Criteria
- •Patients who do not have diabetes mellitus
- •Participating in an interventional trial requiring informed consent
Outcomes
Primary Outcomes
Provide data on patient characteristics
Time Frame: Ten years
Provide data on disease management.
Time Frame: Ten years
Secondary Outcomes
No secondary outcomes reported